Region:Asia
Author(s):Geetanshi
Product Code:KRAE1919
Pages:97
Published On:February 2026

By Type:The genetic testing market can be segmented into various types, including diagnostic testing, predictive testing, carrier testing, prenatal testing, newborn screening, pharmacogenomic testing, and others. Each of these subsegments plays a crucial role in addressing specific healthcare needs, with diagnostic testing being the most widely utilized due to its direct application in disease identification and management. Diagnostic testing demonstrated the fastest growth trajectory among all testing categories.

By End-User:The end-user segmentation includes hospitals, diagnostic laboratories, research institutions, direct-to-consumer services, and others. Hospitals are the primary end-users, as they require genetic testing for patient diagnosis and treatment, while diagnostic laboratories play a significant role in providing specialized testing services. Hospitals demonstrated the fastest growth rate among end-user categories.

The Thailand Genetic Testing Market is characterized by a dynamic mix of regional and international players. Leading participants such as Bangkok Genomics, GeneLab, Chulalongkorn University, Siriraj Hospital, Piyavate Hospital, Bangkok Hospital, Thonburi Healthcare Group, Genetica, MedGenome, Bionet, Pathogenomix, Genomics Thailand, HealthGen, Genomic Health, Genomics for Life contribute to innovation, geographic expansion, and service delivery in this space.
The future of the genetic testing market in Thailand appears promising, driven by technological advancements and increasing public interest in personalized healthcare. As telehealth services expand, more individuals will gain access to genetic counseling and testing, particularly in underserved areas. Additionally, collaborations between private companies and research institutions are expected to foster innovation, leading to the development of more affordable testing solutions that cater to the diverse needs of the population.
| Segment | Sub-Segments |
|---|---|
| By Type | Diagnostic Testing Predictive Testing Carrier Testing Prenatal Testing Newborn Screening Pharmacogenomic Testing Others |
| By End-User | Hospitals Diagnostic Laboratories Research Institutions Direct-to-Consumer Others |
| By Application | Oncology Cardiovascular Diseases Neurological Disorders Rare Diseases Others |
| By Technology | Next-Generation Sequencing (NGS) Polymerase Chain Reaction (PCR) Microarray Sanger Sequencing Others |
| By Distribution Channel | Online Sales Offline Sales Others |
| By Region | Central Thailand Northern Thailand Northeastern Thailand Southern Thailand |
| By Policy Support | Government Subsidies Tax Incentives Research Grants Others |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Healthcare Providers | 120 | Genetic Counselors, Physicians, Lab Technicians |
| Consumers Interested in Genetic Testing | 100 | Potential Test Recipients, Patients with Family History |
| Insurance Companies | 40 | Underwriters, Policy Analysts, Claims Managers |
| Regulatory Bodies | 40 | Health Policy Makers, Regulatory Affairs Specialists |
| Academic Institutions | 50 | Researchers, Professors, Students in Genetics |
The Thailand Genetic Testing Market is valued at approximately USD 283 million. This growth is attributed to increased awareness of genetic disorders, advancements in technology, and the rising prevalence of chronic diseases, driving demand for personalized medicine and preventive healthcare solutions.